What's in a Name? Serous Neoplasms of the Ovary and Fallopian Tube: Classification Updates, Conundrums, and Outcomes - GYNSERNEO03W.2023
Untitled Document


This anatomic pathology activity is intended for practicing pathologists, as well as pathology trainees.

Credit Type: CME
Duration: 1 hour 45 minutes
Launch Date: March 6, 2023
Expiration Date: March 5, 2026 111:59 PM (CT)
Pricing: Junior Member Fee: $10.00
MOC Category: Medical Knowledge. Patient Care

Description
The practicing pathologist, whether in a community or academic setting, commonly encounters serous neoplasms of the ovary and fallopian tube. However, correct application of updated nomenclature which can alter patient management can be challenging. Keep up to date with diagnostic learning. This activity covers diagnostic dilemmas using a case study method, starting at the frozen section/case presentation and ending with the final diagnosis. It covers areas such as serous cystadenomas with proliferation versus borderline tumors, sampling, and diagnosis of tumors with micropapillary architecture, and features of low-grade carcinoma including implant classification. Learners will review problematic cases of high-grade serous carcinoma, including diagnosis and reporting of post-neoadjuvant high-grade serous carcinoma, overlap with low-grade carcinoma, and diagnostic features of serous tubal intraepithelial carcinoma. Each case is used to instruct about recent updates to the World Health Organization classification, molecular characteristics which can be exploited in routine practice for diagnosis and clinical management, and implications of diagnosis for patient outcomes and treatment.

This activity was originally presented at CAP22.

Objectives
After completing this activity, you should be able to:

  1. Recognize and apply the classification scheme for serous neoplasms of the ovary and fallopian tube.
  2. Integrate ancillary diagnostic testing appropriately to maximize patient outcomes.
  3. Differentiate clinical management and outcomes for patients based on diagnosis.
Authors/Faculty
Natalie Banet, MD, FCAP
Deyin Xing, MS, BM, MBBS, PhD

CME Information
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a maximum of 1.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Payment Information
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.

College of American Pathologists
CAP Learning
325 Waukegan Road
Northfield, IL 60093-2750

Refund Policy
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at education@cap.org or fax at 847-832-8006.

Technical Requirements
Pop-up blockers must be turned off.

The CAP recognizes that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online activity. If you experience difficulty or have any questions, please contact a representative of the Customer Contact Center at 800-323-4040 option 1 or education@cap.org.

Availability
This activity and evaluation are available March 6, 2023, and expire March 5, 2026, at 11:59 PM (CT). Upon completion of the activity your credit will be awarded. Your certificate may be downloaded from your Transcript.

CC: GYNSERNEO03W.2023






Non-Member Price:   $91.00  
 
Member Price:  $70.00   


What's in a Name? Serous Neoplasms of the Ovary and Fallopian Tube: Classification Updates, Conundrums, and Outcomes